Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Presynaptic cholinergic dysfunction in patients with dementia.

N R Sims, D M Bowen, S J Allen

Journal of Neurochemistry

|February 1, 1983

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Clinical and diagnostic laboratory immunology·2004

Same author

Increasing incidence of acute hepatitis B virus infection referrals to the Aberdeen Infection Unit: a matter for concern.

Scottish medical journal·2003

Same author

Measures of oxidative stress in heterozygous familial hypercholesterolaemia.

Atherosclerosis·2001

Same author

Expression analysis and chromosome location of a novel gene (H11) associated with the growth of human melanoma cells.

International journal of oncology·2001

Same author

Clinical problem-solving. Less is more.

The New England journal of medicine·2001

Same author

Platelet secretion of beta-amyloid is increased in hypercholesterolaemia.

Brain research·2001

Same journal

A PARK9 iPSC-Derived Dopaminergic Neuron Model Enables Drug Screening Targeting Autophagy-Lysosome Pathway Dysfunction in Parkinson's Disease.

Journal of neurochemistry·2026

Same journal

Opposing Estrous Cycle-Dependent Norepinephrine and Dopamine Regulation in Response to Methamphetamine.

Journal of neurochemistry·2026

Same journal

Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling.

Journal of neurochemistry·2026

Same journal

The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta-Analysis of Public Transcriptional Profiling Data From the Hippocampus and Cortex.

Journal of neurochemistry·2026

Same journal

Splice Type-Specific Effects of Gαo Subunits on Cerebellar Anatomy and Synapse Formation.

Journal of neurochemistry·2026

Same journal

Neurobiological and Behavioral Consequences of Prenatal Methadone or Buprenorphine Exposure: Insight From Animal Models.

Journal of neurochemistry·2026

See all related articles

Alzheimer's disease significantly reduces key markers of cholinergic nerve endings in the brain, impacting acetylcholine synthesis and choline uptake. These findings highlight a critical loss of function in presynaptic cholinergic sites specific to Alzheimer's disease.

Area of Science:

Neuroscience
Biochemistry
Neuropathology

Background:

Presenile dementia is a debilitating condition affecting cognitive function.
Cholinergic pathways are crucial for memory and cognitive processes.
Deficits in cholinergic neurotransmission are implicated in dementia.

Purpose of the Study:

To investigate presynaptic cholinergic nerve ending function in Alzheimer's disease.
To quantify markers of cholinergic activity in neocortical biopsy samples.
To differentiate biochemical changes in Alzheimer's from other forms of dementia.

Main Methods:

Assay of [14C]acetylcholine synthesis, choline acetyltransferase activity, and choline uptake.
Analysis of neocortical biopsy samples from patients with presenile dementia.

Related Experiment Videos

Comparison of biochemical parameters between Alzheimer's patients, other demented patients, and controls.

Main Results:

Confirmed Alzheimer's disease cases showed at least a 40% reduction in all three cholinergic markers.
These reductions were observed in both frontal and temporal lobes.
Biochemical markers were normal in demented patients without Alzheimer's histological features.

Conclusions:

Alzheimer's disease is characterized by significant loss of presynaptic cholinergic nerve ending function.
Reduced acetylcholine synthesis, choline uptake, and ChAT activity are specific biochemical hallmarks.
These findings support the cholinergic hypothesis of Alzheimer's disease.